Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for nonoxynol root_references_@count in root_references_@count (approximate match)

Showing 13911 - 13920 of 19755 results

First page
Previous page
Next page
Next page

Taniraleucel

XO25H8E4QP

Status:

Investigational

Source:

NCT03420963: Phase 1 Interventional Recruiting Recurrent Cutaneous Melanoma

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03420963

Class:

STRUCTURALLY DIVERSE

Surabgene Lomparvovec

GJI4EV4B3C

Status:

Investigational

Source:

INN:surabgene lomparvovec [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/GJI4EV4B3C

Class:

STRUCTURALLY DIVERSE

ITEZOCABTAGENE AUTOLEUCEL

1T1JX1GA68

Status:

Investigational

Source:

INN:itezocabtagene autoleucel [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/1T1JX1GA68

Class:

STRUCTURALLY DIVERSE

Akkermansia muciniphila

ZO2ANP100C

Status:

Investigational

Source:

NCT04303481: Not Applicable Interventional Completed Gut Microbiota

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04303481

Class:

STRUCTURALLY DIVERSE

EMIPLACEL

DPX6XLD4X1

Status:

Investigational

Source:

NCT03451916: Phase 3 Interventional Completed Hip Fracture

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03451916

Class:

STRUCTURALLY DIVERSE

Limosilactobacillus reuteri DSM-17938

SZN3F6U556

Status:

Investigational

Source:

NCT01046617: Phase 3 Interventional Completed Infantile Colic

(2009)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01046617

Class:

STRUCTURALLY DIVERSE

ROVOCTOCOGENE DURPARVOVEC

63QD0BX9B4

Status:

Investigational

Source:

NCT03003533: Phase 1/Phase 2 Interventional Completed Hemophilia A

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03003533

Class:

STRUCTURALLY DIVERSE

Tabelecleucel

G3NJ7M8N4H

Status:

Investigational

Source:

NCT03394365: Phase 3 Interventional Recruiting Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03394365

Class:

STRUCTURALLY DIVERSE

LEUKOCYTE-PLATELET RICH FIBRIN

GYA4K5K9DN

Status:

Investigational

Source:

NCT04717765: Not Applicable Interventional Completed Oral Mucositis

(2021)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04717765

Class:

STRUCTURALLY DIVERSE

MG-4101

WX2ZW10GHO

Status:

Investigational

Source:

NCT03349502: Phase 2 Interventional Completed Acute Myeloid Leukemia

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03349502

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

Taniraleucel

Structurally Diverse

Surabgene Lomparvovec

Structurally Diverse

ITEZOCABTAGENE AUTOLEUCEL

Structurally Diverse

Akkermansia muciniphila

Structurally Diverse

EMIPLACEL

Structurally Diverse

Limosilactobacillus reuteri DSM-17938

Structurally Diverse

ROVOCTOCOGENE DURPARVOVEC

Structurally Diverse

Structurally Diverse

LEUKOCYTE-PLATELET RICH FIBRIN

Structurally Diverse

MG-4101

Showing 13911 - 13920 of 19755 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1